About Walgreens Boots Alliance (NASDAQ:WBA)
Walgreens Boots Alliance, Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company's products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand). In addition, the Company has investments in Guangzhou Pharmaceuticals Corporation and Nanjing Pharmaceutical Company Limited. The Company operates in around 25 countries, which include the wholesale and distribution network with over 340 distribution centers and more than 180,000 pharmacies, health centers and hospitals in 19 countries.
Industry, Sector and Symbol
Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
SymbolNASDAQ:WBA
CUSIP93142210
Phone847-315-2500
Debt
Debt-to-Equity Ratio0.44%
Current Ratio0.90%
Quick Ratio0.45%
Price-To-Earnings
Trailing P/E Ratio12.53
Forward P/E Ratio10.74
P/E Growth1.05
Sales & Book Value
Annual Sales$118.21 billion
Price / Sales0.54
Cash Flow$6.5492 per share
Price / Cash9.76
Book Value$28.42 per share
Price / Book2.25
Profitability
EPS (Most Recent Fiscal Year)$5.10
Net Income$4.08 billion
Net Margins3.33%
Return on Equity20.38%
Return on Assets8.42%
Miscellaneous
Employees345,000
Outstanding Shares991,670,000
Walgreens Boots Alliance (NASDAQ:WBA) Frequently Asked Questions
What is Walgreens Boots Alliance's stock symbol?
Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."
How often does Walgreens Boots Alliance pay dividends? What is the dividend yield for Walgreens Boots Alliance?
Walgreens Boots Alliance declared a quarterly dividend on Wednesday, April 11th. Shareholders of record on Friday, May 18th will be paid a dividend of $0.40 per share on Tuesday, June 12th. This represents a $1.60 dividend on an annualized basis and a yield of 2.50%. The ex-dividend date is Thursday, May 17th. View Walgreens Boots Alliance's Dividend History.
How will Walgreens Boots Alliance's stock buyback program work?
Walgreens Boots Alliance declared that its board has initiated a share repurchase program on Thursday, October 26th 2017, which allows the company to buyback $1,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Shares buyback programs are usually a sign that the company's board of directors believes its shares are undervalued.
How were Walgreens Boots Alliance's earnings last quarter?
Walgreens Boots Alliance Inc (NASDAQ:WBA) posted its quarterly earnings results on Wednesday, March, 28th. The pharmacy operator reported $1.73 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.55 by $0.18. The pharmacy operator had revenue of $33.02 billion for the quarter, compared to analysts' expectations of $32.20 billion. Walgreens Boots Alliance had a net margin of 3.33% and a return on equity of 20.38%. The firm's quarterly revenue was up 12.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.36 earnings per share. View Walgreens Boots Alliance's Earnings History.
When is Walgreens Boots Alliance's next earnings date?
What guidance has Walgreens Boots Alliance issued on next quarter's earnings?
Walgreens Boots Alliance issued an update on its FY18 earnings guidance on Wednesday, March, 28th. The company provided EPS guidance of $5.85-6.05 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.79.
What price target have analysts set for WBA?
21 analysts have issued 1-year price targets for Walgreens Boots Alliance's shares. Their predictions range from $70.00 to $97.00. On average, they expect Walgreens Boots Alliance's stock price to reach $83.8421 in the next year. View Analyst Ratings for Walgreens Boots Alliance.
Are investors shorting Walgreens Boots Alliance?
Walgreens Boots Alliance saw a decrease in short interest during the month of March. As of March 29th, there was short interest totalling 18,913,282 shares, a decrease of 18.9% from the March 15th total of 23,331,657 shares. Based on an average daily trading volume, of 6,602,404 shares, the days-to-cover ratio is presently 2.9 days. Approximately 2.2% of the shares of the company are short sold.
Who are some of Walgreens Boots Alliance's key competitors?
Some companies that are related to Walgreens Boots Alliance include McDonald's (MCD), Booking (BKNG), Costco Wholesale (COST), Starbucks (SBUX), Lowe's (LOW), Kering (PPRUY), CVS Health (CVS), JD.com (JD), TJX Companies (TJX), Walmart de M�xico y Centroam�rica (WMMVY), eBay (EBAY), Seven & I (SVNDY), Target (TGT), Compass Group (CMPGY), Ross Stores (ROST), Yum! Brands (YUM), Tesco (TSCDY) and Dollar General (DG).
Who are Walgreens Boots Alliance's key executives?
Walgreens Boots Alliance's management team includes the folowing people:
- James A. Skinner, Executive Chairman of the Board (Age 72)
- Stefano Pessina, Executive Vice Chairman and Chief Executive Officer (Age 76)
- George R. Fairweather, Executive Vice President and Global Chief Financial Officer (Age 60)
- Ornella Barra, Co-Chief Operating Officer (Age 64)
- Alexander W. Gourlay, Co-Chief Operating Officer (Age 57)
- Kathleen Wilson-Thompson, Executive Vice President, Global Chief Human Resources Officer (Age 60)
- Marco Patrick Anthony Pagni, Executive Vice President, Global Chief Administrative Officer, General Counsel (Age 55)
- Ken Murphy, Executive Vice President, Chief Commercial Officer, President of Global Brands (Age 51)
- Kimberly R. Scardino, Senior Vice President, Chief Accounting Officer, Global Controller (Age 46)
- William C. Foote, Lead Independent Director (Age 66)
Has Walgreens Boots Alliance been receiving favorable news coverage?
Media coverage about WBA stock has trended positive on Sunday, Accern reports. The research group identifies negative and positive media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Walgreens Boots Alliance earned a media sentiment score of 0.25 on Accern's scale. They also assigned headlines about the pharmacy operator an impact score of 47.45 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days.
How do I buy shares of Walgreens Boots Alliance?
Shares of WBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Walgreens Boots Alliance's stock price today?
One share of WBA stock can currently be purchased for approximately $63.92.
How big of a company is Walgreens Boots Alliance?
Walgreens Boots Alliance has a market capitalization of $64.74 billion and generates $118.21 billion in revenue each year. The pharmacy operator earns $4.08 billion in net income (profit) each year or $5.10 on an earnings per share basis. Walgreens Boots Alliance employs 345,000 workers across the globe.
How can I contact Walgreens Boots Alliance?
Walgreens Boots Alliance's mailing address is 108 Wilmot Road, Deerfield IL, 60015. The pharmacy operator can be reached via phone at 847-315-2500 or via email at [email protected]
MarketBeat Community Rating for Walgreens Boots Alliance (WBA)
MarketBeat's community ratings are surveys of what our community members think about Walgreens Boots Alliance and other stocks. Vote "Outperform" if you believe WBA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WBA will underperform the S&P 500 over the long term. You may vote once every thirty days.
Walgreens Boots Alliance (NASDAQ:WBA) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
21 Wall Street analysts have issued ratings and price targets for Walgreens Boots Alliance in the last 12 months. Their average twelve-month price target is $83.8421, suggesting that the stock has a possible upside of 31.17%. The high price target for WBA is $97.00 and the low price target for WBA is $70.00. There are currently 9 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.57 | 2.55 | 2.62 | 2.71 |
| Ratings Breakdown: | 0 Sell Rating(s)
9 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
9 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
8 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
6 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $83.8421 | $85.00 | $86.4211 | $88.8333 |
| Price Target Upside: | 31.17% upside | 28.22% upside | 17.71% upside | 32.02% upside |
Walgreens Boots Alliance (NASDAQ:WBA) Consensus Price Target History
Walgreens Boots Alliance (NASDAQ:WBA) Analyst Ratings History
Show:
(Data available from 4/22/2016 forward)
Walgreens Boots Alliance (NASDAQ:WBA) Dividend Information
Walgreens Boots Alliance pays an annual dividend of $1.60 per share, with a dividend yield of 2.50%. WBA's next quarterly dividend payment will be made on Tuesday, June 12. Walgreens Boots Alliance pays out 31.37% of its earnings out as a dividend.
| Next Dividend: | 6/12/2018 |
| Annual Dividend: | $1.60 |
| Dividend Yield: | 2.50% |
| Payout Ratio: | 31.37% (Trailing 12 Months of Earnings)
26.89% (Based on This Year's Estimates)
24.65% (Based on Next Year's Estimates)
|
Walgreens Boots Alliance (NASDAQ:WBA) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 4/11/2018 | Quarterly | $0.40 | 2.49% | 5/17/2018 | 5/18/2018 | 6/12/2018 |
| 1/19/2018 | quarterly | $0.40 | 2.09% | 2/14/2018 | 2/15/2018 | 3/12/2018 |
| 10/25/2017 | quarterly | $0.40 | 2.31% | 11/10/2017 | 11/13/2017 | 12/12/2017 |
| 7/13/2017 | quarterly | $0.40 | 2.05% | 8/16/2017 | 8/18/2017 | 9/12/2017 |
| 4/21/2017 | quarterly | $0.3750 | 1.79% | 5/16/2017 | 5/18/2017 | 6/12/2017 |
| 1/27/2017 | quarterly | $0.3750 | 1.84% | 2/13/2017 | 2/15/2017 | 3/10/2017 |
| 10/13/2016 | quarterly | $0.3750 | 1.92% | 11/15/2016 | 11/17/2016 | 12/12/2016 |
| 7/14/2016 | quarterly | $0.3750 | 1.79% | 8/17/2016 | 8/19/2016 | 9/12/2016 |
| 4/13/2016 | quarterly | $0.36 | 1.78% | 5/16/2016 | 5/18/2016 | 6/10/2016 |
| 1/29/2016 | quarterly | $0.36 | 1.81% | 2/16/2016 | 2/18/2016 | 3/11/2016 |
| 10/15/2015 | quarterly | $0.36 | 1.65% | 11/12/2015 | 11/16/2015 | 12/11/2015 |
| 7/10/2015 | quarterly | $0.36 | 1.55% | 8/17/2015 | 8/19/2015 | 9/11/2015 |
| 4/9/2015 | quarterly | $0.3375 | 1.46% | 5/19/2015 | 5/21/2015 | 6/12/2015 |
| 1/16/2015 | special | $0.3375 | | 2/13/2015 | 2/18/2015 | 3/12/2015 |
| 10/8/2014 | quarterly | $0.3375 | 2.19% | 11/13/2014 | 11/17/2014 | 12/12/2014 |
| 8/7/2014 | quarterly | $0.3375 | 2.22% | 8/19/2014 | 8/21/2014 | 9/12/2014 |
| 4/9/2014 | quarterly | $0.3150 | 1.99% | 5/19/2014 | 5/21/2014 | 6/12/2014 |
| 1/9/2014 | quarterly | $0.3150 | 2.09% | 2/13/2014 | 2/18/2014 | 3/12/2014 |
| 10/9/2013 | quarterly | $0.3150 | 2.25% | 11/14/2013 | 11/18/2013 | 12/12/2013 |
| 7/10/2013 | quarterly | $0.3150 | 2.59% | 8/16/2013 | 8/20/2013 | 9/12/2013 |
| 4/10/2013 | quarterly | $0.2750 | 2.26% | 5/17/2013 | 5/21/2013 | 6/12/2013 |
| 1/10/2013 | quarterly | $0.2750 | 2.81% | 2/13/2013 | 2/15/2013 | 3/12/2013 |
(Data available from 1/1/2013 forward)
Walgreens Boots Alliance (NASDAQ WBA) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 14.80%
Institutional Ownership Percentage: 60.90%
Walgreens Boots Alliance (NASDAQ WBA) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 1/15/2018 | Stefano Pessina | Insider | Buy | 98,858 | $76.07 | $7,520,128.06 | |  |
| 11/2/2017 | William C Foote | Director | Sell | 2,736 | $67.37 | $184,324.32 | 16,415 | |
| 10/26/2017 | John Anthony Lederer | Director | Buy | 20,000 | $67.00 | $1,340,000.00 | 50,000 | |
| 7/25/2017 | William C Foote | Director | Sell | 2,736 | $79.79 | $218,305.44 | 19,151 | |
| 5/3/2017 | William C Foote | Director | Sell | 2,736 | $85.89 | $234,995.04 | 21,887 | |
| 2/7/2017 | Ornella Barra | COO | Buy | 124,000 | $80.93 | $10,035,320.00 | 1,690,336 | |
| 2/2/2017 | Janice M Babiak | Director | Buy | 600 | $80.68 | $48,408.00 | 600 | |
| 11/28/2016 | Kathleen Wilson-Thompson | EVP | Sell | 5,700 | $85.05 | $484,785.00 | | |
| 11/4/2016 | Stefano Pessina | Insider | Buy | 2,000,000 | $81.41 | $162,820,000.00 | | |
| 11/2/2016 | William C Foote | Director | Sell | 2,067 | $81.30 | $168,047.10 | 24,623 | |
| 9/8/2016 | Kathleen Wilson-Thompson | EVP | Sell | 23,996 | $85.00 | $2,039,660.00 | | |
| 7/26/2016 | William C Foote | Director | Sell | 2,067 | $81.35 | $168,150.45 | 26,690 | |
| 7/14/2016 | Kathleen Wilson-Thompson | EVP | Sell | 29,695 | $83.00 | $2,464,685.00 | | |
| 7/8/2016 | Kathleen Wilson-Thompson | EVP | Sell | 29,695 | $81.03 | $2,406,185.85 | | |
| 6/10/2016 | Kathleen Wilson-Thompson | EVP | Sell | 29,603 | $83.13 | $2,460,897.39 | 128,037 | |
| 5/16/2016 | Barry Rosenstein | Director | Sell | 6,000,000 | $77.29 | $463,740,000.00 | | |
| 4/21/2016 | William C Foote | Director | Sell | 2,066 | $80.99 | $167,325.34 | 28,757 | |
| 4/15/2016 | George Rollo Fairweather | CFO | Sell | 50,000 | $81.52 | $4,076,000.00 | 13,867 | |
| 3/17/2016 | Kathleen Wilson-Thompson | EVP | Sell | 13,728 | $83.01 | $1,139,561.28 | 112,054 | |
| 2/18/2016 | Barry Rosenstein | Director | Sell | 1,720,900 | $76.96 | $132,440,464.00 | | |
| 1/12/2016 | John Anthony Lederer | Director | Buy | 10,000 | $81.00 | $810,000.00 | 30,000 | |
| 11/20/2015 | Barry Rosenstein | Director | Sell | 1,452,470 | $82.37 | $119,639,953.90 | | |
| 11/4/2015 | William C Foote | Director | Sell | 3,500 | $88.36 | $309,260.00 | 30,823 | |
| 11/2/2015 | John Anthony Lederer | Director | Buy | 10,000 | $84.88 | $848,800.00 | 20,000 | |
| 7/16/2015 | William C Foote | Director | Sell | 3,500 | $94.95 | $332,325.00 | | |
| 4/29/2015 | John Anthony Lederer | Director | Buy | 10,000 | $85.00 | $850,000.00 | | |
| 1/29/2015 | Thomas J Sabatino Jr | CAO | Sell | 36,477 | $73.76 | $2,690,543.52 | | |
| 12/15/2014 | Kathleen Wilson-Thompson | SVP | Sell | 40,769 | $73.75 | $3,006,713.75 | | |
| 11/7/2014 | Kermit R Crawford | EVP | Sell | 126,441 | $66.32 | $8,385,567.12 | | |
| 11/3/2014 | Sona Chawla | CMO | Sell | 21,200 | $65.00 | $1,378,000.00 | | |
| 10/14/2014 | Barry Rosenstein | Director | Buy | 1,250,000 | $61.86 | $77,325,000.00 | | |
| 9/19/2014 | Sona Chawla | CMO | Sell | 9,443 | $63.44 | $599,063.92 | | |
| 8/11/2014 | Mia M Scholz | SVP | Sell | 81,015 | $61.93 | $5,017,258.95 | | |
| 8/7/2014 | Gregory D Wasson | CEO | Sell | 24,279 | $60.06 | $1,458,196.74 | | |
| 4/16/2014 | Robert Zimmerman | SVP | Sell | 26,201 | $66.07 | $1,731,100.07 | 53,974 | |
| 4/15/2014 | Kermit Crawford | Insider | Sell | 74,287 | $66.01 | $4,903,684.87 | 90,166 | |
| 1/24/2014 | Graham Atkinson | SVP | Sell | 24,304 | $58.05 | $1,410,847.20 | 48,220 | |
| 1/16/2014 | Robert Zimmerman | SVP | Sell | 10,426 | $60.00 | $625,560.00 | 53,907 | |
| 1/13/2014 | Timothy Theriault | SVP | Sell | 64,815 | $60.50 | $3,921,307.50 | 112,839 | |
| 7/12/2013 | Stefano Pessina | Director | Buy | 34,439 | $45.77 | $1,576,273.03 | | |
| 5/21/2013 | Kermit R Crawford | Insider | Sell | 10,000 | $50.03 | $500,300.00 | | |
| 4/19/2013 | Stefano Pessina | Director | Buy | 83,299 | $48.62 | $4,049,997.38 | | |
(Data available from 1/1/2013 forward)
Walgreens Boots Alliance (NASDAQ WBA) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Shift To Obamacare Bronze Plans Boosts CVS, Walgreens And Walmart Clinics
finance.yahoo.com - April 20 at 5:25 PM |
 | 3 Cheap Dividend Stocks To Consider
seekingalpha.com - April 19 at 5:44 PM |
 | Walgreens Boots Alliance (WBA) Given Buy Rating at Credit Suisse Group
www.americanbankingnews.com - April 18 at 2:58 PM |
| A Look at Rite Aid’s Fiscal 4Q18 Bottom Line
finance.yahoo.com - April 18 at 8:12 AM |
| Amazon About-Face On Drug Sales Not Surprising To Walgreens And CVS
finance.yahoo.com - April 17 at 8:24 AM |
| Detailed Research: Economic Perspectives on General Dynamics, Garmin, Walgreens Boots Alliance, The Home Depot, Facebook, and Apple — What Drives Growth in Today's Competitive Landscape
finance.yahoo.com - April 16 at 8:12 AM |
| Zacks: Brokerages Expect Walgreens Boots Alliance Inc (WBA) Will Announce Quarterly Sales of $33.56 Billion
www.americanbankingnews.com - April 16 at 4:00 AM |
| Express Scripts (ESRX) & Walgreens Boots Alliance (WBA) Head-To-Head Contrast
www.americanbankingnews.com - April 14 at 11:23 PM |
| $1.49 Earnings Per Share Expected for Walgreens Boots Alliance Inc (WBA) This Quarter
www.americanbankingnews.com - April 14 at 9:17 AM |
| Walgreens Boots Alliance Inc (WBA) Sees Significant Decline in Short Interest
www.americanbankingnews.com - April 13 at 2:10 AM |
| Rite Aid To Escalate 'Wellness' Focus For Stores In Albertsons Deal
finance.yahoo.com - April 12 at 5:42 PM |
| Walgreens Boots Alliance Inc (WBA) to Issue $0.40 Quarterly Dividend
www.americanbankingnews.com - April 12 at 10:50 AM |
| Rite Aid tops earnings estimates after completing sale of stores to Walgreens
finance.yahoo.com - April 12 at 8:26 AM |
 | Walgreens Boots Alliance (WBA) Declares $0.40 Quarterly Dividend; 2.5% Yield
www.streetinsider.com - April 11 at 5:36 PM |
| How Wall Street Views Rite Aid Stock ahead of 4Q18 Results
finance.yahoo.com - April 11 at 8:24 AM |
| Underperformers in the Consumer Sector Last Week
finance.yahoo.com - April 10 at 5:32 PM |
| Walgreens Boots Alliance (WBA) Downgraded by BidaskClub
www.americanbankingnews.com - April 10 at 3:25 PM |
| Walgreens Launches the Every One Counts Hometown Challenge in Support of Fourth Annual Red Nose Day in the U.S.
finance.yahoo.com - April 9 at 5:25 PM |
| Walgreens Boots Alliance (WBA) Lowered to "Sell" at BidaskClub
www.americanbankingnews.com - April 9 at 12:24 AM |
| Walgreens Boots Alliance (WBA) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - April 8 at 9:07 AM |
| Walgreens Boots Alliance (WBA) Upgraded to Buy at Zacks Investment Research
www.americanbankingnews.com - April 7 at 1:43 PM |
| Critical Comparison: Diplomat Pharmacy (DPLO) versus Walgreens Boots Alliance (WBA)
www.americanbankingnews.com - April 6 at 5:30 AM |
| Walgreens Boots Alliance (WBA) Price Target Lowered to $73.00 at Pivotal Research
www.americanbankingnews.com - April 5 at 7:58 PM |
| Walgreens Boots Alliance Inc (WBA) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - April 5 at 5:40 PM |
 | Top Stock Reports for Mastercard, Petrobras & Walgreens Boots Alliance
www.zacks.com - April 5 at 5:20 PM |
| Walgreens Supports Surgeon General’s Advisory on Naloxone and Opioid Overdose
finance.yahoo.com - April 5 at 10:05 AM |
| Walgreens committed to making opioid overdose antidote available, as per Surgeon General's advisory
finance.yahoo.com - April 5 at 10:05 AM |
| Q3 2018 Earnings Estimate for Walgreens Boots Alliance Inc (WBA) Issued By Jefferies Group
www.americanbankingnews.com - April 5 at 7:54 AM |
| Walgreens Boots Alliance (WBA) Given a $93.00 Price Target at Jefferies Group
www.americanbankingnews.com - April 4 at 4:42 PM |
| Walgreens Boots Alliance (WBA) Rating Increased to Hold at Zacks Investment Research
www.americanbankingnews.com - April 4 at 12:45 PM |
| Jefferies Group Analysts Lift Earnings Estimates for Walgreens Boots Alliance Inc (WBA)
www.americanbankingnews.com - April 4 at 6:44 AM |
| Jefferies Group Reiterates "$85.00" Price Target for Walgreens Boots Alliance (WBA)
www.americanbankingnews.com - April 3 at 9:37 AM |
| Walgreens Boots' Retail Business Solid Amid Several Concerns
finance.yahoo.com - April 2 at 5:30 PM |
| Walmart, Not Amazon, May Turn Out To Be The Real Health Care Disruptor
finance.yahoo.com - April 2 at 5:30 PM |
| Walgreens Boots Alliance (WBA) PT Lowered to $91.00
www.americanbankingnews.com - April 2 at 2:36 PM |
| Blog Exposure - Rite Aid Completed Transfer of All 1,932 Stores to Walgreens Boots Alliance
finance.yahoo.com - April 2 at 8:33 AM |
| Noses On! Walgreens Welcomes Red Nose Day Back to America as the Exclusive Retailer of the New Sparkle Red Nose
finance.yahoo.com - April 2 at 8:33 AM |
| Today’s Research Reports on Stocks to Watch: Rite Aid and Walgreens
finance.yahoo.com - April 2 at 8:33 AM |
| Walgreens Boots Alliance (WBA) Upgraded at BidaskClub
www.americanbankingnews.com - March 31 at 4:22 PM |
| No Recommendation Changes after Walgreens Releases 2Q18 Results
finance.yahoo.com - March 31 at 8:16 AM |
| [$$] Walmart-Humana Talks Put New Pressure on Remaining Players in Health Care
finance.yahoo.com - March 31 at 8:16 AM |
| Walgreens Boots Alliance (WBA) Given a $90.00 Price Target by Loop Capital Analysts
www.americanbankingnews.com - March 30 at 5:08 PM |
| Walgreens Beat 2Q18 Earnings Expectations, Raised Guidance
finance.yahoo.com - March 30 at 8:18 AM |
| Q3 2018 Earnings Forecast for Walgreens Boots Alliance Inc (WBA) Issued By SunTrust Banks
www.americanbankingnews.com - March 30 at 7:05 AM |
| Leerink Swann Research Analysts Increase Earnings Estimates for Walgreens Boots Alliance Inc (WBA)
www.americanbankingnews.com - March 30 at 7:04 AM |
| Walgreens Boots Alliance Inc (WBA) Expected to Announce Quarterly Sales of $33.14 Billion
www.americanbankingnews.com - March 30 at 3:04 AM |
| Walgreens Boots Alliance's (WBA) Buy Rating Reiterated at Needham & Company LLC
www.americanbankingnews.com - March 29 at 6:22 PM |
| Walgreens: Here’s What Drove Its Fiscal 2Q18 Top Line
finance.yahoo.com - March 29 at 5:33 PM |
| Walgreens Boots Alliance (WBA) Given a $70.00 Price Target at Pivotal Research
www.americanbankingnews.com - March 29 at 3:37 PM |
| BidaskClub Upgrades Walgreens Boots Alliance (WBA) to "Sell"
www.americanbankingnews.com - March 29 at 11:11 AM |
Walgreens Boots Alliance (NASDAQ:WBA) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Walgreens Boots Alliance (NASDAQ:WBA) Income Statement, Balance Sheet and Cash Flow Statement
Walgreens Boots Alliance (NASDAQ WBA) Stock Chart for Sunday, April, 22, 2018
Loading chart…
